AXA 1125
Alternative Names: AXA-1125Latest Information Update: 27 Dec 2023
Price :
$50 *
At a glance
- Originator Axcella Health
- Class Amino acids; Anti-inflammatories; Antifibrotics; Hepatoprotectants
- Mechanism of Action Metabolism-modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Post acute COVID 19 syndrome